EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of fusidic acid phonophoresis as a complementary therapy in chronic rhinosinusitis: a randomised clinical trial

Vijay Kage, Anilkumar Harugop, Shobha Kage, Vaishnavi Aghav, Apoorva Biradar, Prashansa Kulkarni

Physiotherapy Quarterly · 25.06.2026 · 95-102

DOI: 10.5114/pq/215477 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Physiotherapy Quarterly, online erschienen am 25.06.2026. Verfasst von Vijay Kage und 5 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic rhinosinusitis (CRS) is a common inflammatory condition that reduces quality of life (QoL). Erythromycin phonophoresis (EMP) has shown therapeutic potential for CRS. While fusidic acid is effective topically for skin infections due to its antibacterial properties, its use in CRS remains unstudied. To compare the efficacy and feasibility of fusidic acid phonophoresis (FAP) and EMP in CRS based on QoL, pain pressure threshold (PPT) and bacterial reduction.

Methods

A randomised clinical study with 32 CRS participants (mean age: experimental 39.5 ± 13.0, control 45.4 ± 9.2 years) compared FAP (experimental n = 16) and EMP (control n = 16) interventions, delivered thrice weekly for 10 sessions. Participants and assessors were blinded, and group allocation was performed using the envelope method. Outcomes included the Sino-Nasal Outcome Test-22 (SNOT-22) for QoL, PPT via pressure algometer and bacterial colony counts, assessed pre- and post-intervention. Feasibility was evaluated based on economic factors, ease of implementation, clinical impact, and potential adverse events.

Results

Normality and variance homogeneity were checked using Shapiro–Wilk and Levene’s tests. Independent and dependent t-tests (p < 0.05) showed significant within-group improvements in FAP (SNOT-22: 23.4 ± 15.0; effect size: 0.72, PPT: −0.49 ± 0.31; effect size: 0.73) and EMP (SNOT-22: 19.19 ± 13.61; effect size: 0.67, PPT: −0.48 ± 0.24; effect size: 0.80) at p < 0.01. Between-group differences were nonsignificant (SNOT-22: p = 0.40, CI: −6.10 to 14.60; PPT: p = 0.89, CI: −0.19 to 0.21), showing no clinical superiority.

Conclusions

FAP is a feasible and effective alternative to EMP in terms of safety, reduced bacterial growth and tenderness with improved QoL in individuals with CRS.

Zitieren

APA

Kage, V., Harugop, A., Kage, S., Aghav, V., Biradar, A., & Kulkarni, P. (2026). Effect of fusidic acid phonophoresis as a complementary therapy in chronic rhinosinusitis: a randomised clinical trial. Physiotherapy Quarterly, 95-102. https://doi.org/10.5114/pq/215477

Vancouver

Kage V, Harugop A, Kage S, Aghav V, Biradar A, Kulkarni P. Effect of fusidic acid phonophoresis as a complementary therapy in chronic rhinosinusitis: a randomised clinical trial. Physiotherapy Quarterly. 2026:95-102. doi:10.5114/pq/215477

BibTeX
@article{Kage2026,
  author = {Kage, Vijay and Harugop, Anilkumar and Kage, Shobha and Aghav, Vaishnavi and Biradar, Apoorva and Kulkarni, Prashansa},
  title = {Effect of fusidic acid phonophoresis as a complementary therapy in chronic rhinosinusitis: a randomised clinical trial},
  journal = {Physiotherapy Quarterly},
  year = {2026},
  pages = {95--102},
  doi = {10.5114/pq/215477}
}
Kostenlos starten →